Market Tracker

04/29 6:45pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

17.16
Delayed Data
As of Apr 29
 -0.01 / -0.06%
Today’s Change
9.51
Today|||52-Week Range
23.30
+27.68%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close17.17
Today’s open17.02
Day’s range16.80 - 17.20
Volume479,303
Average volume (3 months)767,387
Market cap$848.3M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+111.73%
Earnings growth (next 5 years)+73.00%
Revenue growth (last year)+18.34%
P/E ratio62.6
Price/Sales4.76
Price/Book7.08

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.41-1.94%
ADROAduro Biotech Inc-0.68-4.99%
RGENRepligen Corp-0.33-1.22%
HRTXHeron Therapeutics I...-0.17-0.79%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)$0.09
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts